Overview

Study to Assess the Efficacy and Safety of Tizaspray® Versus Sirdalud®, in Patients With Acute Low Back Pain

Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Open label, randomized, controlled, multicenter study with two parallel groups of patients
Phase:
Phase 3
Details
Lead Sponsor:
MDM S.p.A.
Collaborators:
Latis S.r.l.
Opera Contract Research Organization SRL
Opera CRO, a TIGERMED Group Company
Treatments:
Clonidine
Tizanidine